Current NDC auxiliary source row compounder:372

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source: ndc_compounder_zip
Product Ndc Raw: 81375-200
Product Ndc: 81375-200
Product Ndc Digits: 81375200
Product Type Name: HUMAN COMPOUNDED DRUG
Proprietary Name: Prednisolone/Moxifloxacin
Proprietary Name Suffix: [empty]
Nonproprietary Name: Prednisolone 1%/Moxifloxacin 0.5%
Dosage Form Name: SOLUTION/ DROPS
Route Name: OPHTHALMIC
Marketing Category Name: OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name: PQ Pharmacy LLC
Establishment Name: PQ Pharmacy LLC
Establishment Fei: [empty]
Substance Name: PREDNISOLONE SODIUM PHOSPHATE; MOXIFLOXACIN HYDROCHLORIDE
Active Ingredients Info: 10 mg/1 mL; 5 mg/1 mL
History Active Ingredients Raw: PREDNISOLONE SODIUM PHOSPHATE; MOXIFLOXACIN HYDROCHLORIDE
History Active Ingredients Info Raw: 10 mg/1 mL; 5 mg/1 mL
History Dosage Raw: SOLUTION/ DROPS
Dea Schedule: [empty]
Package Ndc Raw: 81375-200-05
Package Ndc: 81375-200-05
Package Ndc Digits: 8137520005
Package Ndc11: 81375020005
Package Description: 5.6 mL in 1 BOTTLE, DROPPER (81375-200-05)
Reporting Period Raw: 2025-2
Reporting Period: 2025-2
Normalization Status: valid
Source Url: https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive: compounders_ndc_directory.zip
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Last Modified: Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256: 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256: f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id: compounder:372
Source Row Number: 372
Source Row Hash: 9c4aa6ad7320a4253c8ec30f856f321045b9d9f11e8c93b19dd03faf9b430a6d
Import Run Id: 20261015T162751Z
Loaded At: 2026-10-15 16:32:20

Exact raw FDA source fields#

{
    "ROUTENAME": "OPHTHALMIC",
    "PRODUCTNDC": "81375-200",
    "DEASCHEDULE": "",
    "LABELERNAME": "PQ Pharmacy LLC",
    "SUBSTANCENAME": "PREDNISOLONE SODIUM PHOSPHATE; MOXIFLOXACIN HYDROCHLORIDE",
    "DOSAGEFORMNAME": "SOLUTION/ DROPS",
    "NDCPACKAGECODE": "81375-200-05",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "Prednisolone/Moxifloxacin",
    "REPORTINGPERIOD": "2025-2",
    "NONPROPRIETARYNAME": "Prednisolone 1%/Moxifloxacin 0.5%",
    "PACKAGEDESCRIPTION": "5.6 mL in 1 BOTTLE, DROPPER (81375-200-05) ",
    "ACTIVEINGREDIENTSINFO": "10 mg/1 mL; 5 mg/1 mL",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset: compounder
Record Source: ndc_compounder_zip
Source Record Id: compounder:372
Source Row Number: 372
Status Scope: package
Lookup Ndc: 81375-200-05
Lookup Ndc Digits: 8137520005
Product Ndc: 81375-200
Product Ndc Digits: 81375200
Package Ndc: 81375-200-05
Package Ndc Digits: 8137520005
Package Ndc11: 81375020005
Product Id: [empty]
Status Code: COMPOUNDER
Status Label: Outsourcing facility compounded drug report
Reporting Period Raw: 2025-2
Reporting Period: 2025-2
Source Table: fda_ndc_aux_compounder
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Row Hash: 9c4aa6ad7320a4253c8ec30f856f321045b9d9f11e8c93b19dd03faf9b430a6d
Import Run Id: 20261015T162751Z
Loaded At: 2026-10-15 16:32:20